Phase II trial in Europe of PLX PAD in patients with critical limb ischaemia.

Trial Profile

Phase II trial in Europe of PLX PAD in patients with critical limb ischaemia.

Planning
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2015

At a glance

  • Drugs PLX PAD (Primary)
  • Indications Peripheral arterial disorders
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pluristem Therapeutics
  • Most Recent Events

    • 10 Aug 2015 Positive results from this trial could be sufficient for conditional approval to market PLX cells in this indication according to a Pluristem Therapeutics media release.
    • 21 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top